Related Experiment Video
Updated: Jun 18, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta
Songyi Xu1, Amber C Liu, Avrum I Gotlieb
1Toronto General Research Institute and Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
Insights
Calcific aortic stenosis and atherosclerosis share similar pathways. Transforming growth factor-beta may be a key therapeutic target for both cardiovascular diseases.
Area of Science:
- Cardiovascular Medicine
- Pathology
- Biochemistry
Background:
- Calcific aortic stenosis and atherosclerosis are distinct cardiovascular conditions.
- Similarities in pathogenesis suggest shared underlying mechanisms.
- Current therapies, like statins, show effects potentially independent of lipid lowering.
Purpose of the Study:
- To discuss the pathogenic features of calcific aortic stenosis and atherosclerosis.
- To highlight the similarities between these two cardiovascular diseases.
- To review evidence for transforming growth factor-beta as a shared therapeutic target.
Main Methods:
- Review of experimental in vitro and in vivo studies.
- Analysis of clinical studies on both conditions.
- Literature synthesis on molecular regulatory roles.
Main Results:
- Identified significant similarities in pathogenic pathways between the two diseases.
- Highlighted the role of various molecules in valve calcification and atherosclerotic plaque progression.
- Presented evidence suggesting transforming growth factor-beta's regulatory role in both conditions.
Conclusions:
- Transforming growth factor-beta is a potential key therapeutic target for both calcific aortic stenosis and atherosclerosis.
- Further study of transforming growth factor-beta is warranted for developing novel treatments.
- Understanding shared pathways may lead to more effective cardiovascular disease management.
Abstract:
Calcific aortic stenosis and atherosclerosis have been investigated separately in experimental in vitro and in vivo studies and in clinical studies. The similarities identified in both diseases suggest that similar pathogenic pathways are involved in both conditions. Most current therapeutic studies are focused on statins. The evidence suggests that statin effects on valves may, in large part, be independent of the lipid lowering effects of the drug. There are several molecules that play significant regulatory roles on the development and progression of valve sclerosis and calcification and on growth and complications of atherosclerotic plaques. The purpose of this review is to discuss the pathogenic features of the two conditions, highlight the important similarities, and then review the data that suggest that transforming growth factor-beta may play a key regulatory role in both diseases and that this is worthy of study as a potential therapeutic target for both conditions.
More Related Videos
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
TGF - β Signaling Pathway
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Regulation of Angiogenesis and Blood Supply
Coronary Artery Disease I: Introduction